Treatment of patients with autonomic insufficiency and postural hypotension due to deficient circulatory reflexes has been unsatisfactory. Dihydroergotamine (DHE) causes selective constriction of capacitance vessels. We have investigated whether this property, by limiting venous pooling in the upright posture,2 is beneficial in postural hypotension.
Methods and results
Six patients with autonomic insufficiency and severe postural hypotension (three men, three women; mean age 67 years, range 50-80) were studied. Standing systolic blood pressure while on no treatment averaged 66-7 mm Hg. Fludrocortisone 0-3 mg/day had been tried in all with little symptomatic benefit. The autonomic insufficiency was of the peripheral pattern in four patients and central in two. Autonomic insufficiency was confirmed by absent or subnormal reflex rise in peripheral vascular resistance with head-up tilting and by an absent Valsalva constrictor response. All patients were on a 160-mmol sodium diet and had taken no drugs for four weeks before entry to the study. The effect of intravenously administered DHE on the haemodynamic response to tilting was assessed in six patients. After arterial pressure, cardiac index (by dye dilution), total peripheral resistance, and central blood volume (CBV) had been measured the patients were tilted head-up to an angle of 15°. In five patients this was well tolerated and the angle was increased to 30°. Measurements were repeated at the highest angle of tilt. DHE 10 ,ug/kg was then administered intravenously over five minutes.
Supine haemodynamic measurements were repeated 10 minutes later and again after tilting.
Blood pressure increased after intravenous DHE and fell less during tilting (P <0-01). Systolic pressure fell from 130 ±93 mm Hg to 98±13 mm Hg before DHE, but after DHE supine systolic pressure was 171 ±2-9 mm Hg and fell to 160 ±8 7 mm Hg. Blood pressure was higher after DHE mainly because there was less venous pooling during tilting, with a smaller fall in CBV. Supine CBV was 1009±81-3 ml/m2 before and 1114±71-4 ml/m2 after DHE. During tilt CBV was 761 ±78-2 ml/m2 before and 981 ± 81-3 ml/m2 after DHE. Changes in the cardiac index passively reflected the changes in CBV. The cardiac index during tilting was 2-34 ±0-4 1/min/m2 before and 3-29 r03 1/min/m2 after DHE (P<0 01). Supine peripheral vascular resistance rose slightly, by 4 mm Hg/l/min/m2 after DHE, suggesting some effect on resistance vessels.
The efficacy of oral DHE was then assessed in four patients. Blood pressure was measured weekly using a random zero sphygmomanometer (Gelman-Hawksley Instruments). Pressures were measured after five minutes each lying and standing. Drugs were administered single blind. Patients started on DHE 5 mg/day in two equal doses. The dose was then increased by 5 mg every two weeks up to 40 mg daily. Fludrocortisone 0 3 mg daily was then added and the combination continued for four weeks. Finally DHE was stopped (replaced by an identical placebo) and fludrocortisone alone continued until postural symptoms reappeared. The effects of oral DHE at the various doses are shown in the figure. In one patient a dose of DHE of 10 mg daily was adequate to maintain standing blood pressure at 150/89 mm Hg and relieve symptoms. The remaining three patients required 30 mg/day to raise standing blood pressure from an average of 80/51 mm Hg to 107/67 mm Hg (P<0-001) with 
Comment
Our study confirms the finding2 3 that intravenously administered DHE acutely improves postural hypotension in patients with autonomic insufficiency and shows that benefit results from long-term oral administration. The haemodynamic changes suggested that DHE constricts capacitance vessels so that less pooling occurs in veins on standing.2 The venoconstrictor effect of DHE seems to be due mainly to x-adrenoceptor stimulation.4 Although DHE has constrictor and dilator effects the former would be expected to be exaggerated in the denervated vessels of these patients.5
The lack of effect of oral doses of DHE below 20 mg/day in three patients contrasted with their response to acute intravenous DHE. The subsequent effect when the dose was increased beyond 20 mg suggests that low-bioavailability of DHE was a problem at the lower doses. In other studies doses of 2 to 10 mg/day3 have been used and previous "failures" may well have been due to inadequate dosage. Addition of fludrocortisone to DHE in all patients resulted in further improvement in standing blood pressure, suggesting that the two drugs have additive effects.
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2 Nordenfeldt, I, and Mellander, S, Acta Medica Scandinavica, 1972, 191, 115. 3 Bevegard, S, Castenfors, J, and Lindblad, L-E, Acta Medica Scandinavica, 1974, 196, 473. 4 Aellig, W H, European Journal of Clinical Pharmacology, 1974, 7, 137. 6 Mellander, S, and Nordenfeldt, I, Clinical Science, 1970, 39, 183 Interaction between chloramphenicol and paracetamol While studying hepatic microsomal glucuronidation in children with kwashiorkor, we observed that when chloramphenicol and paracetamol were given together the half life of chloramphenicol was prolonged from the normal 2-3 hours' to 18-24 hours. We then decided to study this interaction in adults receiving chloramphenicol in an intensive care unit.
Patients, methods, and results
Six patients in the intensive care unit, all of whom had an infection and had received broad-spectrum antibiotics, were given chloramphenicol, 1 g intravenously. Blood samples were taken after i, 1, 1i, and 2 hours and the chloramphenicol concentration measured.' The patients were then given paracetamol, 100 mg intravenously, and further blood samples were taken at 3, 4, 5, and 6 hours after the chloramphenicol had been given. Thereafter the patients received a full course of chloramphenicol.
The results ( figure) show that before paracetamol was given the half life of chloramphenicol was 3-25 hours. After paracetamol was given, however, the elimination of chloramphenicol was reduced, and the half life of chloramphenicol increased to 15 hours.
Comment
Chloramphenicol usage and toxicity have been reviewed.2 The inhibition of phenytoin, tolbutamide, chlorpropamide, and dicoumarol metabolism by chloramphenicol is well known.3 We suggest that chloramphenicol elimination is appreciably decreased by simultaneously giving paracetamol, probably because of competitive metabolism. This is important because, at least in underdeveloped societies, chloramphenicol is widely used, being cheap and readily available and the usual treatment for typhoid. It is often given with an
